Active Surveillance

Active surveillance is considered a treatment option if a cancer is not causing any symptoms and is expected to grow slowly. In the past this approach was mainly suggested to elderly men, or men with serious health problems; however, younger men have started to consider this treatment option. Since prostate cancer often spreads very slowly, many men who have the disease may never require treatment. In many men, it is a means of delaying or deferring therapy and potential quality of life changes associated with current treatment options. Typically, patients on an active surveillance program undergo regular PSA measurements and periodic prostate biopsies to ensure that the cancer is not becoming more aggressive. If there is a change in the prostate cancer then the patient can make a decision to undergo active treatment with either surgery or radiation. Approximately 30% of cancers will progress within 5 years. The intent of active surveillance is curative.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

VPC Terry Fox team 2016

Terry Fox Run - September 20, 2020

The 40th annual Terry Fox Run takes place on Sunday September 20 across Canada, as a virtual event.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Thursday, March 4, 2021

Dr. Collins awarded CIHR Project Grant

Dr. Colin Collins
Friday, January 22, 2021

Dr. Nappi receives MSFHR 2020 Health Professional-Investigator Award